benzinga.comPreethi Sundaram Implements A Sell Strategy: Offloads $103K In Catalyst Pharmaceuticals Stockabout 1 month ago
finance.yahoo.comWith 75% ownership of the shares, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is heavily dominated by institutional owners9 months ago
finance.yahoo.comCatalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 202410 months ago
finance.yahoo.comCatalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE in Japan10 months ago
finance.yahoo.comSanthera Announces Half-Year 2024 Financial Results and Provides Corporate Update10 months ago
finance.yahoo.comCatalyst Pharmaceuticals to Participate in Upcoming Investor Conferences11 months ago